MED12 and neoplasm: In that study MED12 mutation in the tumor was found to increase the magnitude of differential expression of a number of lncRNAs (TPTEP1, PART1, RPS10P7, MSC-AS1, LINC00337, LINC00536, LINC01436, LINC01449, LINC02433, LINC01186, and LINC02624).